Need a report that reflects how COVID-19 has impacted this market and its growth?
The Middle East and Africa Patient Monitoring Market are expected to grow with a CAGR of 4.8% in the forecast period.
COVID-19 is expected to have a significant impact on the growth of the market. COVID-19 increased the demand for patient monitoring in the Middle East and Africa region owing to the restriction of patients' visits to the hospital. Government organizations provided various services to help monitor the condition of patients infected with COVID-19. For instance, in April 2020 the Saudi Ministry of Health launched an app aimed at monitoring the conditions of people suspected of having Coronavirus disease (COVID-19). Such government initiatives provided to monitor the condition of patients contributed to the growth of the market during the pandemic period. Also, during the post-pandemic period, the increasing adoption of patient monitoring in the Middle East and Africa region is expected to contribute to the growth of the market.
The key factors propelling the growth of the market are the rising burden of chronic diseases due to lifestyle changes, growth in the geriatric population, growing preference for home and remote monitoring, and ease of use and portability devices to promote growth. According to GLOBOCAN 2020, it was estimated that around 27,885 new cancer cases were reported in Saudi Arabia in 2020. Similarly, it was estimated that around 4,807 new cancer cases in the United Arab Emirates (UAE) and 3,842 new cancer cases were reported in Kuwait in 2020, respectively. With the high burden of cancer in the country, demand for effective treatment procedures also increases. This is ultimately helping in driving the biologics market growth in the GCC region. Also, according to the United Nations Population Fund’s World Population Dashboard’s Statistics 2021, in Kuwait, approximately 3.4% of the population of the country is aged 65 years and above. In addition, as per the World Population Ageing 2020 Report, in the United Arab Emirates, the population aged 60 years or above (thousands) in 2019 was 113 and the number is estimated to reach 1,679 by the year 2050. As the geriatric population is prone to suffer from various chronic diseases such as cardiovascular diseases, hypertension, diabetes, and others, are anticipated increase in population is expected to fuel the demand for the patient monitoring market.
Patient monitoring technologies identify small changes in the patient’s physiological data, hence promoting self-monitoring. Thus, it reduces readmissions and prevents avoidable hospitalizations, decreases the number of unnecessary trips to the doctor’s office, and reduces travel-related expenses. On a short- and long-term basis, by the proper implementation, patient monitoring technologies can expand access to quality healthcare and save time and money.
Thus the above-mentioned factors are expected to drive the demand for the growth of the market during the forecast period.
Scope of the report
As per the scope of this report, patient monitoring devices are monitoring devices that continuously monitor the patient’s vital parameters, like blood pressure and heart rates, by using a medical monitor and collecting medical (and other) data from individuals. The Middle East and Africa Patient Monitoring Market is Segmented by Type of Device (Hemodynamic Monitoring Devices, Neuromonitoring Devices, Cardiac Monitoring Devices, Multi-parameter Monitors, Respiratory Monitoring Devices, and Other Types of Devices), Application (Cardiology, Neurology, Respiratory, Fetal and Neonatal, Weight Management and Fitness Monitoring, and Other Devices), End User (Home Care Settings, Hospital and Clinics, and Other End Users), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The report offers the value (in USD million) for the above-mentioned segments.
|By Type of Device|
|Hemodynamic Monitoring Devices|
|Cardiac Monitoring Devices|
|Other Types of Devices|
|Fetal and Neonatal|
|By End User|
|Hospitals and Clinics|
|Other End Users|
Key Market Trends
Hemodynamic Monitoring Devices Segment is Expected to Grow Fastest Over the Forecast Period
The key factors propelling the growth of this market are an increase in the number of critically ill geriatric cases, a rise in the prevalence of cardiac disorders and diabetes, and increasing demand for home-based and non-invasive monitoring systems. With the increasing prevalence of cardiovascular diseases and other chronic diseases in the region, market growth also increases. As per the International Diabetes Federation 10th Edition 2021, 803.4 (in 1,000s) people were suffering from diabetes in 2021 in Kuwait, and the number is estimated to reach 1,051.4 (in 1,000s) by the year 2030 and 1,267.4 by 2050. Similarly, per the same source, 990.9 (in 1,000s) people were suffering from diabetes in 2021 in the United Arab Emirates and the number is estimated to reach 1,177.5 (in 1,000s) by the year 2030 and 1,325.8 by 2050. Thus, with the increasing burden of diabetes, the demand for healthcare management apps for managing and controlling diabetes is increasing which is expected to fuel the market growth. Also, in The study “Identifying co-occurrence and clustering of chronic diseases using latent class analysis: cross-sectional findings from SAGE South Africa Wave 2” published in January 2021, the prevalence of coexistence of two or more non-communicable diseases (NCDs) was 21% in the significantly high country. Thus, the growing burden of chronic diseases in the country is expected to increase the demand for hemodynamic monitoring devices.
Factors such as technological advancements in hemodynamic monitoring systems, increasing research into hemodynamic monitoring systems further boost the market.
To understand key trends, Download Sample Report
South Africa is Expected to Dominate the Middle East and Africa Patient Monitoring Market Over the Forecast Period
South Africa is expected to dominate the market during the forecast period due to the increasing demand for patient monitoring as there was a rise in the geriatric population and the prevalence of chronic diseases.
For instance, according to the 2022 statistics published by the United Nations Population Fund, in South Africa, a large proportion of the living population is aged 15-64 and accounts for 66% in 2022. In addition, as per the same source, 6% of the population is aged 65 years and above in 2022.
Also, according to International Diabetes Federation, in November 2021, titled “With 1 in 9 adults living with diabetes, South Africa has highest diabetes prevalence in Africa”, the highest rate of diabetes prevalence in Africa has been recorded in South Africa, at 11.3% in 2020.
Thus, the rising geriatric populations are more prone to develop chronic diseases which require proper monitoring and diagnosis which is expected to increase the adoption of patient monitoring.
To understand geography trends, Download Sample Report
The Middle East and Africa Patient Monitoring Market is s highly competitive and consists of a few major players. Companies, like Abbott Laboratories, Boston Scientific Corporation, Becton, Dickinson and Company, General Electric Company (GE Healthcare), Johnson & Johnson, and Medtronic Care Management Services LLCamong others, hold substantial shares in the market.
- In March 2022, BioIntelliSense Inc collaborated with Mubadala Health, the integrated healthcare network of Mubadala Investment company. This collaboration incorporated BioIntelluSense's innovative remote care technologies with Mubadala BiointelliSense's innovative remote care technologies with Mubadala Health's continuous care model to drive clinical workflow efficiencies.
- In March 2022 Cardo Health launched the telemedicine app Kena Health in South Africa. Kena Health targets the millions of uninsured citizens who are dependent on stressed public health systems using a B2C freemium business model.
Table of Contents
1. RESEARCH METHODOLOGY
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study
2. EXECUTIVE SUMMARY
3. MARKET DYNAMICS
3.1 Market Overview
3.2 Market Drivers
3.2.1 Rising Burden of Chronic Diseases due to Lifestyle Changes
3.2.2 Growing Preference for Home and Remote Monitoring
3.3 Market Restraints
3.3.1 Resistance from Healthcare Industry Professionals Toward the Adoption of Patient Monitoring Systems
3.3.2 High Cost of Technology
3.4 Porter's Five Force Analysis
3.4.1 Threat of New Entrants
3.4.2 Bargaining Power of Buyers/Consumers
3.4.3 Bargaining Power of Suppliers
3.4.4 Threat of Substitute Products
3.4.5 Intensity of Competitive Rivalry
4. MARKET SEGMENTATION (Market Size by Value – USD million)
4.1 By Type of Device
4.1.1 Hemodynamic Monitoring Devices
4.1.2 Neuromonitoring Devices
4.1.3 Cardiac Monitoring Devices
4.1.4 Multi-parameter Monitors
4.1.5 Other Types of Devices
4.2 By Application
4.2.4 Fetal and Neonatal
4.3 By End User
4.3.1 Home Healthcare
4.3.2 Hospitals and Clinics
4.3.3 Other End Users
4.4.1 Middle East and Africa
22.214.171.124 South Africa
126.96.36.199 Rest of Middle East and Africa
5. COMPETITIVE LANDSCAPE
*List Not Exhaustive
5.1 Company Profiles
5.1.1 Abbott Laboratories
5.1.2 Boston Scientific Corporation
5.1.3 Becton, Dickinson and Company
5.1.4 General Electric Company (GE Healthcare)
5.1.5 Johnson & Johnson
5.1.6 Medtronic Plc
5.1.7 Koninklijke Philips NV
5.1.8 Siemens Healthcare GmbH
6. MARKET OPPORTUNITIES AND FUTURE TRENDS
You can also purchase parts of this report. Do you want to check out a section wise price list?
Frequently Asked Questions
What is the study period of this market?
The Middle East and Africa Patient Monitoring Market market is studied from 2019 - 2027.
What is the growth rate of Middle East and Africa Patient Monitoring Market?
The Middle East and Africa Patient Monitoring Market is growing at a CAGR of 4.8% over the next 5 years.
Who are the key players in Middle East and Africa Patient Monitoring Market?
Abbott Laboratories, Boston Scientific Corporation, Becton, Dickinson and Company, General Electric Company (GE Healthcare), Johnson & Johnson are the major companies operating in Middle East and Africa Patient Monitoring Market.